ALVO
Price
$9.19
Change
-$0.45 (-4.67%)
Updated
Apr 2 closing price
Capitalization
3.48B
34 days until earnings call
CRON
Price
$1.81
Change
+$0.02 (+1.12%)
Updated
Apr 2 closing price
Capitalization
1B
40 days until earnings call
Ad is loading...

ALVO vs CRON

Header iconALVO vs CRON Comparison
Open Charts ALVO vs CRONBanner chart's image
Alvotech
Price$9.19
Change-$0.45 (-4.67%)
Volume$168.91K
Capitalization3.48B
Cronos Group
Price$1.81
Change+$0.02 (+1.12%)
Volume$1.02M
Capitalization1B
ALVO vs CRON Comparison Chart
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. CRON commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and CRON is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ALVO: $9.19 vs. CRON: $1.81)
Brand notoriety: ALVO and CRON are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALVO: 108% vs. CRON: 62%
Market capitalization -- ALVO: $3.48B vs. CRON: $1B
ALVO [@Pharmaceuticals: Other] is valued at $3.48B. CRON’s [@Pharmaceuticals: Other] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green whileCRON’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • CRON’s FA Score: 0 green, 5 red.
According to our system of comparison, ALVO is a better buy in the long-term than CRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish while CRON’s TA Score has 3 bullish TA indicator(s).

  • ALVO’s TA Score: 4 bullish, 5 bearish.
  • CRON’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALVO is a better buy in the short-term than CRON.

Price Growth

ALVO (@Pharmaceuticals: Other) experienced а -20.43% price change this week, while CRON (@Pharmaceuticals: Other) price change was +0.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.71%. For the same industry, the average monthly price growth was -0.38%, and the average quarterly price growth was -8.58%.

Reported Earning Dates

ALVO is expected to report earnings on May 07, 2025.

CRON is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.71% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($3.48B) has a higher market cap than CRON($1.01B). CRON YTD gains are higher at: -10.396 vs. ALVO (-30.537). CRON has higher annual earnings (EBITDA): -71.8M vs. ALVO (-493.67M). CRON has more cash in the bank: 862M vs. ALVO (11.2M). CRON has less debt than ALVO: CRON (2.55M) vs ALVO (1.08B). ALVO (91.4M) and CRON (87.2M) have equivalent revenues.
ALVOCRONALVO / CRON
Capitalization3.48B1.01B346%
EBITDA-493.67M-71.8M688%
Gain YTD-30.537-10.396294%
P/E Ratio57.47N/A-
Revenue91.4M87.2M105%
Total Cash11.2M862M1%
Total Debt1.08B2.55M42,107%
FUNDAMENTALS RATINGS
CRON: Fundamental Ratings
CRON
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
57
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOCRON
RSI
ODDS (%)
Bullish Trend 1 day ago
59%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 13 days ago
63%
Bullish Trend 17 days ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 6 days ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BSMIX15.870.25
+1.60%
iShares Russell Small/Mid-Cap Idx Instl
LGRCX19.64N/A
N/A
Loomis Sayles Growth C
COAGX48.95N/A
N/A
Gator Capital L/S Fd
SHTCX35.49N/A
N/A
Columbia Seligman Global Tech C
MITEX13.47N/A
N/A
Matthews Asia Innovators Institutional

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and AKAN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and AKAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-4.67%
AKAN - ALVO
24%
Poorly correlated
-1.44%
CURLF - ALVO
21%
Poorly correlated
-1.93%
CRON - ALVO
20%
Poorly correlated
+1.12%
ELAN - ALVO
20%
Poorly correlated
+4.06%
PRGO - ALVO
20%
Poorly correlated
+0.76%
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been closely correlated with SNDL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRON jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
+1.12%
SNDL - CRON
73%
Closely correlated
N/A
TLRY - CRON
69%
Closely correlated
-0.43%
CGC - CRON
68%
Closely correlated
+2.94%
ACB - CRON
66%
Loosely correlated
+2.29%
OGI - CRON
62%
Loosely correlated
-0.96%
More